Rekhi B, Bhatnagar D, Bhatnagar A, Saxena S
Institute of Pathology, ICMR, Safdarjang Hospital, New Delhi, India.
Cytopathology. 2005 Oct;16(5):219-26. doi: 10.1111/j.1365-2303.2005.00261.x.
Exact categorization of soft tissue tumours (STTs) on smears requires application of various ancillary techniques. This study was aimed at evaluating the role of fluorescent immunocytochemistry (FICC) in cyto-diagnosis of 30 STT cases.
Thirty cases of soft tissue tumours were included in the present study. All cases were subjected to routine Giemsa and Papanicolaou stain. Extra smears were made and kept for fluorescent immunostaining. A panel of cytoskeletal antibodies, tagged with FITC (Fluorescein isothyocynate), was employed in all these cases. Fluorescent immunostained smears were examined under Zeiss Confocal Laser scanning microscope, using double immunofluorescence (red-green). Finally, all cases were subjected to biopsy and again immunoperoxidase staining.
Among the 30 cases in the present study, unaided cytological diagnoses ranged from 'spindle cell' tumour in four (13.3%) cases, benign and malignant spindle cell tumour in 17 (56.6%) cases, to malignant mesenchymal tumour in nine (30%) cases. FICC helped in further correct categorization of 25/30 (83.3%) cases viz. leiomyoma (three), benign neurogenic tumour (six), schwannoma (one), dermatofibrosarcoma protuberans (three), synovial sarcoma (two), rhabdomyosarcoma (two), malignant fibrous histiocytoma (five) and malignant peripheral nerve sheath tumour (three). Aggressive fibromatosis was found to be a missed diagnosis in two cases. Overall concordance between cyto-diagnosis with FICC, and histopathology results was 83.3% (P < 0.05).
Fluorescent immunocytochemistry is a significant ancillary technique for making a rapid and specific diagnosis of STT, as required for their timely management. Incorporation of a wide panel of antibody markers with clinico-cytological correlation is recommended in forming an exact diagnosis in these cases.
对涂片上的软组织肿瘤(STT)进行准确分类需要应用多种辅助技术。本研究旨在评估荧光免疫细胞化学(FICC)在30例STT病例细胞诊断中的作用。
本研究纳入30例软组织肿瘤病例。所有病例均进行常规吉姆萨和巴氏染色。制作额外涂片并保存用于荧光免疫染色。所有这些病例均使用一组用异硫氰酸荧光素(FITC)标记的细胞骨架抗体。在蔡司共聚焦激光扫描显微镜下使用双免疫荧光(红绿)检查荧光免疫染色涂片。最后,所有病例均进行活检并再次进行免疫过氧化物酶染色。
在本研究的30例病例中,未经辅助的细胞学诊断范围从4例(13.3%)的“梭形细胞”肿瘤、17例(56.6%)的良性和恶性梭形细胞肿瘤到9例(30%)的恶性间叶肿瘤。FICC有助于对25/30(83.3%)的病例进行进一步准确分类,即平滑肌瘤(3例)、良性神经源性肿瘤(6例)、神经鞘瘤(1例)、隆突性皮肤纤维肉瘤(3例)、滑膜肉瘤(2例)、横纹肌肉瘤(2例)、恶性纤维组织细胞瘤(5例)和恶性外周神经鞘瘤(3例)。在2例病例中发现侵袭性纤维瘤病被漏诊。FICC细胞诊断与组织病理学结果的总体一致性为83.3%(P<0.05)。
荧光免疫细胞化学是一种重要的辅助技术,可用于快速、特异性地诊断STT,这是其及时治疗所必需的。建议在这些病例中结合广泛的抗体标志物面板以及临床细胞学相关性来进行准确诊断。